A7L Stock Chart & Stats
€0.01
€0.42(3809.09%)
At close: 4:00 PM EST
€0.01
€0.42(3809.09%)
Day’s Range― - ―
52-Week Range€0.38 - €0.43
Previous CloseN/A
Volume4.00K
Average Volume (3M)4.00K
Market Cap
€10.39M
Enterprise Value€3.72M
Total Cash (Recent Filing)€1.13M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Sep 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding79,185,265
10 Day Avg. Volume4,000
30 Day Avg. Volume4,000
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)3.47
Price to Sales (P/S)0.00
P/FCF Ratio-2.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Zero Financial DebtThe absence of financial debt reduces refinancing exposure and avoids interest obligations that could further pressure a loss-making business. This gives Amur greater balance-sheet flexibility to preserve capital, pursue project work, or negotiate future funding without an existing lender burden.
Clinical Development ProgressProgress toward Phase II execution represents a meaningful development milestone and can improve visibility around the company’s lead program. Advancing trial sites and recruitment creates an opportunity to generate clinical evidence that may support future partnerships, funding, or commercialization.
Focused Project PortfolioA concentrated focus on a primary mineral project can direct limited technical and corporate resources toward advancing one defined asset rather than dispersing effort across unrelated opportunities. If successfully progressed, the project could provide pathways to a sale, partnership, or future development.
Bears Say
Minimal And Inconsistent RevenueThe lack of recurring revenue means the company currently has little operating income to fund exploration, development, or corporate costs. This leaves future value dependent on project advancement, asset transactions, or external financing rather than an established commercial revenue base.
Persistent Cash BurnPersistent negative operating and free cash flow shows that the business does not currently self-fund its activities. Worsening cash burn increases reliance on external capital and can constrain the pace of exploration, development, clinical work, and other value-creating initiatives.
Deep, Volatile LossesDeep losses and sharply negative returns indicate limited operating leverage and weak conversion of the capital base into earnings. Continued deterioration in equity reduces financial resilience, while earnings volatility makes planning and funding future project milestones more difficult.
Amur Minerals News
A7L FAQ
What was Amur Minerals Corporation’s price range in the past 12 months?
Amur Minerals Corporation lowest stock price was €0.38 and its highest was €0.43 in the past 12 months.
What is Amur Minerals Corporation’s market cap?
Amur Minerals Corporation’s market cap is €10.39M.
When is Amur Minerals Corporation’s upcoming earnings report date?
Amur Minerals Corporation’s upcoming earnings report date is Sep 23, 2026 which is in 10 days.
How were Amur Minerals Corporation’s earnings last quarter?
Amur Minerals Corporation released its earnings results on Jun 26, 2026. The company reported -€0.028 earnings per share for the quarter.
Is Amur Minerals Corporation overvalued?
According to Wall Street analysts Amur Minerals Corporation’s price is currently Overvalued.
Does Amur Minerals Corporation pay dividends?
Amur Minerals Corporation does not currently pay dividends.
What is Amur Minerals Corporation’s EPS estimate?
Amur Minerals Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amur Minerals Corporation have?
Amur Minerals Corporation has 79,185,265 shares outstanding.
What happened to Amur Minerals Corporation’s price movement after its last earnings report?
Amur Minerals Corporation reported an EPS of -€0.028 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Amur Minerals Corporation?
Currently, no hedge funds are holding shares in DE:A7L
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amur Minerals Corporation
CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.